Methylene blue alleviates experimental autoimmune encephalomyelitis by modulating AMPK/SIRT1 signaling pathway and Th17/Treg immune response-Reference-Cited by-同舟云学术

Methylene blue alleviates experimental autoimmune encephalomyelitis by modulating AMPK/SIRT1 signaling pathway and Th17/Treg immune response

Published:2016-10 Issue: Volume:299 Page:45-52
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Wang Jueqiong,Zhao Congying,Kong Peng,Bian Guanyun,Sun Zhe,Sun Yafei,Guo Li,Li Bin

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Reference55 articles.

1. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice;Bettelli;J. Immunol.,1998

2. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity;Cantó;Nature,2009

3. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB;Chen;EMBO J.,2002

4. Anti-IL-23 therapy inhibitsmultiple inflammatory pathways and ameliorates autoimmune encephalomyelitis;Chen;J. Clin. Invest.,2006

5. Origins of the T(H)1–T(H)2 model: a personal perspective;Coffman;Nat. Immunol.,2006

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective effect of methylene blue in iron-induced neurotoxicity;Medical Hypotheses;2024-04

2. Neuroprotective effect of curcumin against experimental autoimmune encephalomyelitis-induced cognitive and physical impairments in mice: an insight into the role of the AMPK/SIRT1 pathway;Inflammopharmacology;2023-12-19

3. Sirtuin family in autoimmune diseases;Frontiers in Immunology;2023-07-06

4. LKB1 isoform expression modulates T cell plasticity downstream of PKCθ and IL-6;Molecular Immunology;2023-05

5. Repurposing Methylene Blue for the Management of COVID-19: Prospects, Paradox, and Perspective;Drug Repurposing for Emerging Infectious Diseases and Cancer;2023